Introduction

Lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) occur in 50% of men over the age of 50 years, and prevalence increases with age. Patients traditionally have been managed with a combination of medical and surgical treatments. Transurethral resection of the prostate is the gold standard for surgical treatment of BPH. Within the past decade, prostate artery embolization (PAE) has emerged as a minimally invasive alternative for the treatment of BPH, urinary retention, and hematuria of prostatic origin.

Source: Techniques in Vascular and Interventional Radiology - October 5, 2020 Category: Radiology Authors: Shivank Bhatia Source Type: research